IDEXX Laboratories, Inc. IDXX is well-poised to grow confidence, backed by solid gains in CAG (Companion Animal Group) Diagnostics’ recurring revenues. Strong momentum in the expansion of the ProCyte ...
Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide "ProCyte One reimagines point-of-care hematology with a ...
IDEXX's business model relies on selling diagnostic equipment, consumables, veterinary software, and diagnostic imaging to generate recurring revenue. The company has experienced double-digit growth ...
IDEXX Laboratories, Inc. IDXX is likely to grow in the coming quarters, backed by the sustained success of CAG’s recurring diagnostic products and services. The company’s international business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results